glucose lowering for cardiovascular prevention

     

Select
Display
Trial Studied trt Control trt patientstagsNCTROB Result

diabetes type 2

canagliflozin
CANVAS, 2017canagliflozinplaceboNCT01032629Exploratory suggesting
dapagliflozin
DECLARE TIMI 58 ongoing dapagliflozinplaceboNCT01730534Exploratory ongoing
empagliflozin
EMPA-REG OUTCOME, 2015empagliflozinplaceboNCT01131676Low risk of bias conclusive
linagliptin
CAROLINA, 2012linagliptinglimepirideNCT01243424Exploratory suggesting
liraglutide
LEADER, 2016liraglutideplaceboNCT01179048Exploratory suggesting